Correlation Between Citigroup and Emcure Pharmaceuticals
Specify exactly 2 symbols:
By analyzing existing cross correlation between Citigroup and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Citigroup and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Emcure Pharmaceuticals.
Diversification Opportunities for Citigroup and Emcure Pharmaceuticals
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Citigroup and Emcure is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Citigroup i.e., Citigroup and Emcure Pharmaceuticals go up and down completely randomly.
Pair Corralation between Citigroup and Emcure Pharmaceuticals
Taking into account the 90-day investment horizon Citigroup is expected to generate 0.82 times more return on investment than Emcure Pharmaceuticals. However, Citigroup is 1.21 times less risky than Emcure Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Emcure Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 6,203 in Citigroup on September 23, 2024 and sell it today you would earn a total of 716.00 from holding Citigroup or generate 11.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.46% |
Values | Daily Returns |
Citigroup vs. Emcure Pharmaceuticals
Performance |
Timeline |
Citigroup |
Emcure Pharmaceuticals |
Citigroup and Emcure Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Citigroup and Emcure Pharmaceuticals
The main advantage of trading using opposite Citigroup and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.Citigroup vs. Nu Holdings | Citigroup vs. Canadian Imperial Bank | Citigroup vs. Bank of Montreal | Citigroup vs. Bank of Nova |
Emcure Pharmaceuticals vs. Akums Drugs and | Emcure Pharmaceuticals vs. Innova Captab Limited | Emcure Pharmaceuticals vs. Kingfa Science Technology | Emcure Pharmaceuticals vs. Rico Auto Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |